Patent intelligence · US
US 9468669
Methods to treat dysregulated blood glucose disorders
Methods to treat dysregulated blood glucose disorders
Patent details — US 9468669
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 18, 2016
- Expiration
- Oct 13, 2036
- Applicant
- Regents of the University of Minnesota
- Claims
- 16
- CPC classes
- A61K, A61K31/198, A61K31/42, A61K38/28
Quick answer
US 9468669 (Methods to treat dysregulated blood glucose disorders) is held by Regents of the University of Minnesota. Status: granted. Granted Oct 18, 2016. Expires Oct 13, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K31/198, A61K31/42, A61K38/28, A61K45/06, A61K9/0019
More from Regents of the University of Minnesota
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 9468669?
US 9468669 (Methods to treat dysregulated blood glucose disorders) is held by Regents of the University of Minnesota. Status: granted. Granted Oct 18, 2016. Expires Oct 13, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9468669?
Regents of the University of Minnesota is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 9468669 expire?
Our index shows an expiration date of Oct 13, 2036 (10 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.